NASDAQ | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 8.63% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 8.28% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 8.09% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.93% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.89% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 4.54% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.29% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.15% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.03% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.73% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.54% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.53% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.51% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.41% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.34% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.34% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.31% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.29% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 1.28% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.25% |
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.